Trafficking the NGF signal: implications for normal and degenerating neurons

被引:49
作者
Delcroix, JD
Valletta, J
Wu, CB
Howe, CL
Lai, CF
Cooper, JD
Belichenko, PV
Salehi, A
Mobley, WC [1 ]
机构
[1] Stanford Univ, Dept Neurol & Neurol Sci & Pediat, Stanford, CA 94305 USA
[2] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA
来源
NGF AND RELATED MOLECULES IN HEALTH AND DISEASE | 2004年 / 146卷
关键词
nerve growth factor; signal transduction; endosome; Down syndrome; Alzheimer's disease;
D O I
10.1016/S0079-6123(03)46001-69
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Nerve growth factor (NGF) activates TrkA to trigger signaling events that promote the survival, differentiation and maintenance of neurons. The mechanism(s) that controls the retrograde transport of the NGF signal from axon terminals to neuron cell bodies is not known. The 'signaling endosome' hypothesis stipulates that NGF, TrkA and signaling proteins are retrogradely transported on endocytic vesicles. Here, we provide evidence for the existence of signaling endosomes. Following NGF treatment, clathrin-coated vesicles (CCVs) contain NGF bound to TrkA together with activated signaling proteins of the Ras/pErk 1/2 pathway. NGF signals from isolated CCVs through the Erk1/2 pathway. Early endosomes appear to represent a second type of signaling endosomes. We found that NGF induced a sustained activation of Rap1, a small monomeric GTP-binding protein of the Ras family, and that this activation occurred in early endosomes that contain key elements of Rap1/pErk1/2 pathway. We discuss the possibility that the failure of retrograde NGF signaling in a mouse model of Down syndrome (Ts65Dn) may be due to the failure to retrograde transport signaling endosomes. It is important to define further the significance of signaling endosomes in the biology of both normal and degenerating neurons.
引用
收藏
页码:3 / 23
页数:21
相关论文
共 72 条
  • [1] The TrkB-Shc site signals neuronal survival and local axon growth via MEK and PI3-kinase
    Atwal, JK
    Massie, B
    Miller, FD
    Kaplan, DR
    [J]. NEURON, 2000, 27 (02) : 265 - 277
  • [2] Beattie EC, 2000, J NEUROSCI, V20, P7325
  • [3] ASSOCIATION OF THE RAS-ANTAGONISTIC RAP1/KREV-1 PROTEINS WITH THE GOLGI-COMPLEX
    BERANGER, F
    GOUD, B
    TAVITIAN, A
    DEGUNZBURG, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (05) : 1606 - 1610
  • [4] Bhattacharyya A, 1997, J NEUROSCI, V17, P7007
  • [5] High-resolution imaging demonstrates dynein-based vesicular transport of activated Trk receptors
    Bhattacharyya, A
    Watson, FL
    Pomeroy, SL
    Zhang, YZZ
    Stiles, CD
    Segal, RA
    [J]. JOURNAL OF NEUROBIOLOGY, 2002, 51 (04): : 302 - 312
  • [6] Maintenance of human T cell anergy: Blocking of IL-2 gene transcription by activated Rap1
    Boussiotis, VA
    Freeman, GJ
    Berezovskaya, A
    Barber, DL
    Nadler, LM
    [J]. SCIENCE, 1997, 278 (5335) : 124 - 128
  • [7] PIT FORMATION AND RAPID CHANGES IN SURFACE-MORPHOLOGY OF SYMPATHETIC NEURONS IN RESPONSE TO NERVE GROWTH-FACTOR
    CONNOLLY, JL
    GREEN, SA
    GREENE, LA
    [J]. JOURNAL OF CELL BIOLOGY, 1981, 90 (01) : 176 - 180
  • [8] Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion
    Cooper, JD
    Salehi, A
    Delcroix, JD
    Howe, CL
    Belichenko, PV
    Chua-Couzens, J
    Kilbridge, JF
    Carlson, EJ
    Epstein, CJ
    Mobley, WC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) : 10439 - 10444
  • [9] Cunningham ME, 1997, J BIOL CHEM, V272, P10957
  • [10] DAVIES PJA, 1984, DIABETES CARE, V7, P35